ALFA Finder| Revenue growth | 18.2% YoY growth to ₹126.2 Cr, driven by specialized tertiary care. |
|---|---|
| Margins | EBITDA margin at 20.4%; management targets 21% by fiscal year-end. |
| Demand visibility | Strong demand for tertiary care in underserved Eastern/Central India markets. |
| Management confidence | Confident but defensive regarding Raipur losses and Agartala occupancy fluctuations. |
Growth
Revenue grew 18.2% YoY driven by complex quaternary procedures and robotic surgeries despite occupancy dips in Agartala.
Outlook
Targets 25% long-term ROE/ROCE; Jamshedpur facility (155 beds) commissioning in Q4 FY27.
Risks
High attrition in non-Kolkata markets (10% Agartala/Raipur) and continued losses (₹3 Cr) at the new Raipur facility.
Last quarter's promises, checked
Delivered
- Guided 15% revenue growth → delivered 18.2% (= BEAT)
- Guided Raipur breakeven by Q3 FY27 → delivered on track with losses narrowing (= BEAT)
- Guided 70% occupancy in mature units → delivered 58-71% range (= BEAT)
Partly delivered
- Guided 7-8% ARPOB growth → delivered 5.9% (= PARTIAL)
- Guided Jamshedpur Q4 FY27 commissioning → delivered on track (= PARTIAL)
Missed
- Guided 30% Raipur occupancy by year-end → delivered 14.26% (= MISS)
- Guided 20.2% EBITDA margin → delivered 18.8% (= MISS)
Earnings Call Transcript filed with BSE, NSE: GPTHEALTH. Summary written with AI assistance from the document.
GPT Healthcare Ltd: key numbers
- Share price
- ₹145.02
- Market cap
- ₹1,190 Cr
- Revenue (annual)
- ₹472.6 Cr
- Net profit (annual)
- ₹42.22 Cr
- P/E (TTM)
- 22.9×Sector 54.5×
- Promoter holding
- 65.57%+0.00% QoQ
- FII holding
- 3.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from GPT Healthcare Ltd
All →GPT Healthcare Earnings Call Transcript: Key Takeaways
Q2 revenue rose 14.1% to ₹135.6 Cr and EBITDA 23.9%, driven by occupancy and volume. Raipur break-even slipped from Q3 FY27 to Q1 FY28 amid ~₹9 Cr Q2 losses. Management gave no new quantified targets beyond FY27 growth.
GPT Healthcare Results Update
GPT Healthcare filed a press release on unaudited Q2 and H1 FY27 results, reporting H1 total income of Rs 266.8 Cr and PAT of Rs 28.1 Cr. The release carries a P&L highlights table without the full SEBI results statement.
GPT Healthcare Investor Presentation: Key Takeaways
Q2 FY27 revenue ₹135.6 Cr (+14.0%), EBITDA ₹29.8 Cr (21.5% margin), PAT ₹15.4 Cr (+45.2%). H1 PAT ₹28.1 Cr (+53.9%). Eastern India expansion; 1,000-bed target.
GPT Healthcare Dividend
GPT Healthcare's board declared an interim dividend of ₹1.00 per share for FY2026-27. Record date is November 12, 2026, with payment expected by December 4, 2026.
GPT Healthcare Q2 FY27 Results: Net Profit ₹15.4 Cr, Up 45.3% YoY
GPT Healthcare approved unaudited Q2 and half-year results, with H1 revenue of Rs 26,182.60 lakh. A 10% interim dividend was declared with a November 12 record date.
- Key figure
- Net profit ₹15.4 Cr · +45.3% YoY
GPT Healthcare Board Meeting Date
GPT Healthcare will hold a board meeting on 05 Nov 2026 to consider Q2 and half-year unaudited results and a possible interim dividend for FY 2026-27. Trading window stays closed until 07 Nov 2026.